Pet Pharm Biotech Co (ROCO:7762) Other Operating Expense: NT$0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7762 Pet Pharm Biotech Co Ltd ROCO:7762
26 GF Score
Price NT$60.10
! 5 Warning Signs
View Full Analysis

What is Pet Pharm Biotech Co Other Operating Expense?

Pet Pharm Biotech Co ROCO:7762 +3.80% 26 Other Operating Expense is NT$0.0 Mil as of Jun. 2026. GuruFocus rates ROCO:7762 with a GF Score™ of 26/100. The stock has 5 warning signs investors should review.

Pet Pharm Biotech Co's Other Operating Expense for the six months ended in Jun. 2026 was NT$0.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was NT$0.0 Mil.

Pet Pharm Biotech Co's quarterly Other Operating Expense declined from Jun. 2025 (NT$0.0 Mil) to Dec. 2025 (NT$0.0 Mil) but then stayed the same from Dec. 2025 (NT$0.0 Mil) to Jun. 2026 (NT$0.0 Mil).

Pet Pharm Biotech Co's annual Other Operating Expense increased from Dec. 2023 (NT$0.0 Mil) to Dec. 2024 (NT$0.0 Mil) but then declined from Dec. 2024 (NT$0.0 Mil) to Dec. 2025 (NT$-0.0 Mil).

Pet Pharm Biotech Co Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Pet Pharm Biotech Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pet Pharm Biotech Co Other Operating Expense Chart

Pet Pharm Biotech Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Operating Expense
0.00 0.00 0.00 -0.00

Pet Pharm Biotech Co Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Operating Expense Get a 7-Day Free Trial 0.00 -0.00 0.00 0.00 0.00
ROCO:7762
26GF Score
Pet Pharm Biotech Co Ltd ROCO:7762
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pet Pharm Biotech Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of NT$0.0 Mil mean?
Pet Pharm Biotech Co (ROCO:7762) has a Other Operating Expense of NT$0.0 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Pet Pharm Biotech Co and its competitors.
Is Pet Pharm Biotech Co's Other Operating Expense too high?
Pet Pharm Biotech Co's current Other Operating Expense is NT$0.0 Mil. Overall, Pet Pharm Biotech Co has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Pet Pharm Biotech Co's Other Operating Expense compare to LLY and JNJ?
Pet Pharm Biotech Co's Other Operating Expense of NT$0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Pet Pharm Biotech Co and its competitors. Pet Pharm Biotech Co's current Other Operating Expense is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pet Pharm Biotech Co stock overvalued right now?
Pet Pharm Biotech Co (ROCO:7762) has a current Other Operating Expense of NT$0.0 Mil. The current Other Operating Expense is NT$0.0 Mil. Pet Pharm Biotech Co's overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Pet Pharm Biotech Co (ROCO:7762), the current Other Operating Expense is NT$0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pet Pharm Biotech Co Business Description

Address 143, Hougang 1st Road, 1-2F., No. 141, Xinzhuang District, New Taipei City, TWN, 242051
Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.
26GF Score

Get the complete analysis for ROCO:7762

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$60.10
Price